To this end, we evaluated if DIA-ME can recapitulate the effect in human osteosarcoma cells (U-2 OS) that were treated with Interferon gamma (IFN-γ), an extensively characterized model to study cellular immune response via JAK/STAT signaling (reviewed in refs. 41–43). Here, IFNG is linked to osteosarcoma.